AstraZeneca PLC is 28.7x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $9.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARWR | AZN |
|---|---|---|
| Market cap | $9.96 B | $286.27 B |
| US-listed rank | #941 | #45 |
| Revenue (latest FY) | $829.45M | - |
| Net income (latest FY) | -$1.63M | - |
| Net margin | -0.2% | - |
| SEC filings | 1,347 | 1,004 |
AstraZeneca PLC is 28.7x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $9.96 B).
Full pages: ARROWHEAD PHARMACEUTICALS, INC. and AstraZeneca PLC, or browse the full rankings.